SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001626199-21-000081
Filing Date
2021-06-02
Accepted
2021-06-02 18:14:54
Documents
2
Period of Report
2021-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_162267205891359.html 3  
1 FORM 3 wf-form3_162267205891359.xml 3 1752
2 POWER OF ATTORNEY alpn-section16powerofattor.htm EX-24 2236
  Complete submission text file 0001626199-21-000081.txt   5587
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Issuer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALPINE IMMUNE SCIENCES, INC. 188 EAST BLAINE STREET, SUITE 200 SEATTLE WA 98102
Business Address
Goldberg Zelanna (Reporting) CIK: 0001861993 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37449 | Film No.: 21990575